NorthCrest Asset Manangement’s Royalty Pharma RPRX Stock Holding History

NorthCrest Asset Manangement’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	+4,744	New	+$247K	0.01%	755

Other funds holding RPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

KMC

Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Cooper Investors Melbourne, Victoria, Australia $218M AUM 0.39% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return

NorthCrest Asset Manangement's RPRX Position: Q2 2026 in Review

NorthCrest Asset Manangement opened a new position in Royalty Pharma (RPRX) in Q2 2026: 4,744 shares worth $275K. The stake represents 0.01% of the portfolio and ranks #755 among its holdings.

54 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

NorthCrest Asset Manangement held 4,744 shares of Royalty Pharma worth $275K as of Q2 2026.
Royalty Pharma was a new NorthCrest Asset Manangement position in Q2 2026.
Royalty Pharma made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #755 holding.
54 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.